Share on LinkedInShare on LinkedIn

ARTICLE · 26 JANUARY 2021

Subject-Matter Eligibility At The EPO: Life Sciences

Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
Contributor
Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Finnegan, Henderson, Farabow, Garrett & Dunner LLP is one of the world’s largest firms focusing on...

View firm profile
Explore more from Finnegan, Henderson, Farabow, Garrett & Dunner LLP

Subject-matter eligibility at the USPTO for life sciences inventions can be a minefield, and in recent years, numerous articles and webinars have tried to get a handle ...

European UnionIntellectual Property

Subject-matter eligibility at the USPTO for life sciences inventions can be a minefield, and in recent years, numerous articles and webinars have tried to get a handle on what sort of claims might be allowed by the USPTO (our most recent webinar on this topic may be found here). Happily, subject-matter eligibility is much less controversial at the EPO, and the case law is generally consistent, although not entirely without U-turns. In this blog post, we summarise the types of claims that are acceptable at the EPO and look at ways of minimising future subject-matter eligibility issues when drafting.

Exclusions

The EPO does not allow inventions that are contrary to "ordre public" or morality when commercially exploited.1 More specifically, this excludes patents relating to:

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from